Inhibrx Biosciences, Inc.
INBX
$89.47
$0.370.42%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -25.34% | -18.60% | -22.03% | -17.76% | -- |
| Total Receivables | -13.08% | -57.86% | -25.73% | -30.28% | -29.61% |
| Inventory | -17.63% | -5.91% | -26.28% | -49.71% | -77.26% |
| Prepaid Expenses | 135.68% | 19.78% | -30.26% | -63.98% | -33.06% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -21.27% | 28.63% | -7.88% | -27.86% | 32.15% |
| Total Current Assets | -23.30% | -17.19% | -22.19% | -19.87% | 1,475.03% |
|
|
|||||
| Total Current Assets | -23.30% | -17.19% | -22.19% | -19.87% | 1,475.03% |
| Net Property, Plant & Equipment | -33.75% | -31.54% | 22.68% | 17.98% | 31.70% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -35.65% | -35.91% | -14.51% | 0.95% | 48.34% |
| Total Assets | -24.18% | -18.97% | -20.26% | -17.92% | 759.75% |
|
|
|||||
| Total Accounts Payable | -37.96% | -22.85% | -7.04% | -4.70% | 0.22% |
| Total Accrued Expenses | -45.20% | -17.57% | -26.43% | 3.70% | 28.29% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 22.05% | 45.83% | 22.45% | -0.09% | -6.80% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -39.25% | -17.02% | -18.40% | -0.29% | 13.55% |
|
|
|||||
| Total Current Liabilities | -39.25% | -17.02% | -18.40% | -0.29% | 13.55% |
| Long-Term Debt | 77.38% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -40.79% | -36.05% | -- | -- | 952.41% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 38.33% | 193.51% | 218.95% | 267.61% | 280.07% |
|
|
|||||
| Common Stock & APIC | 6.03% | 6.03% | 5.68% | 5.51% | 2,364.49% |
| Retained Earnings | -87.11% | -131.96% | -266.16% | -1,136.53% | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -122.27% | -94.02% | -79.36% | -68.75% | 976.91% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -122.27% | -94.02% | -79.36% | -68.75% | 976.91% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -122.27% | -94.02% | -79.36% | -68.75% | 976.91% |
|
|
|||||